Selank vs Semax: different research questions

Selank

A tuftsin-derived peptide investigated in stress-response research. Research explores interactions between pathways involved in anxiety and immune regulation. A proposed mechanism alone does not predict an individual response. Small regional human studies reported anxiety-related findings. Independent replication and a broad modern trial base remain limited. Regional research or authorization does not establish worldwide approval or the safety of this laboratory material. This listing is Selank, not an acetylated or amidated variant.

Semax

A peptide investigated in neurotrophic signalling and neurological research. Proposed mechanisms include BDNF-related and neurotransmitter pathways. Researchers have examined responses in experimental neurological models. Regional clinical publications include cerebrovascular studies. Limited independent replication makes broad cognition claims difficult to support. Evidence for a specific medical formulation does not establish the effects of a research vial. Regional regulatory history is distinct from local authorization. This listing is Semax itself, not a chemically modified variant.

Comparison limits

A shared category does not prove equal effects, compatibility or suitability. Verify the exact sequence, formulation and batch. Do not substitute a related molecule or ingredient finding for direct evidence.

Compare the catalogue identifiers